Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1
By F. Martínez, S. Gordon, M. Locati, A. Mantovani. Journal of Immunology, 2006
1,978 citations recorded by the source corpus.
Subfields: Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/01e52fd24d6168be425e9c1853642d36d1488434
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Oncology
Citations in the corpus
- From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation (2014, background): “Thus, CSF-1 stimulation represents a default homeostatic/M2 pathway of monocyte development (119).”
- Macrophage plasticity and polarization: in vivo veritas. (2012, positive): “Chemokines and CSF-1 are more than monocyte attractants; they also promote M2-like skewing of macrophage function (97, 118, 119).”
- Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets (2019, methodology): “E) (Top to Bottom) Enrichment analysis of M1-like macrophage signature in Br-TAM: Plot suggests that M1-like genes (Martinez et al., 2006) to be positively (NES = 2.”
- Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms (2019, background): “In vitro, addition of activated M1-like macrophages to dorsal root ganglion (DRG) neuron cultures leads to axonal retraction and failure of regeneration as the expression of CSPGs is much higher in M1-like compared to M2-like macrophages (237, 238).”
- The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases (2016, background): “Therefore, M2 activation is accompanied by upregulation of arachidonic acid [19], omega-3 polyunsaturated fatty acids [24], sphingosine 1-phosphate [25], eicosapentaenoic acid, and docosahexaenoic acid [26].”
- Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. (2014, methodology): “…FFAs upregulate proinflammatory cytokine expression in ATMs and fail to induce the M2 markers CD163, CD206, TFRC, and TGFBI (Becker et al., 2012; Martinez et al., 2006), properties that clearly distinguish these cells from M2 macrophages, which also induce lipid metabolism through PPARg…”
- Tumor‐associated macrophages (TAM) as major players of the cancer‐related inflammation (2009, background): “Martinez at al [48] analyzed the transcriptional profiling of the human monocyte-to-macrophage differentiation and they observed that the polarization to M1 of MCSF-differentiated macrophages was associated with the most dramatic change in the transcriptome, whereas further stimulation with an M2 st”
- Tumor associated macrophages and neutrophils in cancer. (2013, background): “M2 macrophages produce chemokines such as CCL17/TARC, CCL22/MDC and CCL24/Eotaxin-2, involved in Treg cell, Th2, eosinophil and basophil recruitment (Mantovani et al. 2002; Martinez et al. 2006; Romagnani et al. 1999).”
- Alternative activation of macrophages: mechanism and functions. (2010, background): “…it possible to investigate effects of IL-4 in macrophages of both species; however, given the limited number of published studies in human or mouse macrophages, a consensus of markers is hard to establish, particularly for humans (Syed et al., 2007; Martinez et al., 2006; Scotton et al., 2005).”
- Novel Markers to Delineate Murine M1 and M2 Macrophages (2015, result): “To validate these data, we compared the current gene expression profiles with canonical M1 macrophage markers previously identified in mouse [23,41] or human macrophages [4,14,34].”